POLYTHÉRAPIE POUR LE TRAITEMENT DU CANCER
- 专利权人:
- Inc.;Millennium Pharmaceuticals
- 发明人:
- LABOTKA, Richard,FERGUS, Andrew
- 申请号：
- EP16752904
- 公开号：
- EP3258965A4
- 申请日:
- 2016.02.16
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- POLYTHERAPIE POUR LE TRAITEMENT DU CANCER
- SPECIFIC POINT INHIBITORS
- Combination of HDAC inhibitor and anti-PD-1 antibody for cancer treatment
- Combination of an anti-PD-L1 antibody and a DNA-PK inhibitor for the treatment of cancer
- COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER
